Study analysis · genesis · 2003
Turning off one gene after birth made mice muscles grow as big as if it was turned off from conception.
Turning off a muscle-limiting gene in baby mice after they were born made their muscles grow just as big as if the gene had been turned off since they were embryos.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study looked at mice and changed one gene to see what happened to their muscles. It showed that the muscles got bigger, but it didn't compare them to other mice or prove the gene change caused it. So we can only say 'this happened' — not 'this caused that'.
What’s the bottom line?
Scientists turned off a gene called myostatin in baby mice after they were born, and their muscles grew as big as in mice that had the gene turned off from birth.
How strong is this study?
The scientists used a smart trick to change the gene, but we don't know if they were fair in how they picked the mice or if they made sure no one knew which mice got changed. That makes it hard to trust the results fully — like doing a science experiment without a control group.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
0 / 100
- Randomizationrandomization unclear
- Blindingblinding unclear
- Control groupno control group
- Sample sizeno sample size reported
- Follow-upno follow-up reported
100 / 100
0 / 100
- P-valuesno p-values reported
- Effect sizeno effect size reported
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 56 / 100
Probability of being correct
Researchers compare people who have a condition (cases) with similar people who do not (controls), looking back in time for differences in exposure. Useful but more prone to bias.
This design cannot establish causation — the findings describe an association, not a cause. Study design cannot establish causation because randomization, blinding, and control group status are unknown, and the abstract describes an animal study with no explicit experimental control structure to infer causality.
No Conflicts
No conflicts of interest identified
No conflicts of interest or funding information were disclosed in the provided text, and the study appears to be independently conducted.
The abstract contains no information regarding funding, author affiliations, or conflicts of interest. No indicators of industry influence or bias are present in the provided text.
Key takeaways
- 01
Muscle growth after postnatal gene inactivation was equal to growth in mice with the gene turned off from conception.
- 02
Yes — if this works similarly in humans, it could help people with muscle wasting diseases grow more muscle.
Surprising findings
- Postnatal myostatin inactivation produced the same muscle growth as lifelong knockout.It was widely assumed that muscle growth potential was locked in during embryonic development; this shows the gene continues to regulate mass throughout life.
Practical takeaways
Consider myostatin-blocking therapies as a future option for age-related or disease-induced muscle loss.
This study was done in mice using genetic engineering; no human trials or drugs are confirmed yet.
low confidenceWhy this study matters
Muscle Growth After Birth
Postnatal, muscle-specific inactivation of the myostatin gene in mice caused muscular hypertrophy equal in magnitude to constitutive myostatin knockout, meaning muscle growth occurred fully even when the gene was turned off after birth.
This challenges the idea that muscle development is fixed early in life — suggesting we might one day reverse muscle loss in adults by targeting this gene.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists turned off a gene called myostatin in baby mice after they were born, and their muscles grew as big as in mice that had the gene turned off from birth.
Research results
Muscle growth after postnatal gene inactivation was equal to growth in mice with the gene turned off from conception.
What this means - more context
Yes — if this works similarly in humans, it could help people with muscle wasting diseases grow more muscle.
To determine whether postnatal inactivation of the myostatin gene in striated muscle can induce muscular hypertrophy comparable to constitutive knockout.
Postnatal, muscle-specific inactivation of the myostatin gene in mice causes muscular hypertrophy equal in magnitude to constitutive myostatin knockout, demonstrating that myostatin regulates muscle mass throughout postnatal development and that striated muscle is its functional production site.
Methods Used
Conditional gene targeting using the cre-lox system in mice to inactivate the myostatin gene postnatally in striated muscle; comparison with constitutive myostatin knockout mice. Methodology details not available in abstract.
Main Finding
Postnatal myostatin inactivation in striated muscle causes muscular hypertrophy of the same magnitude as constitutive myostatin knockout.
Confidence Level
Limited - based on abstract only, full methodology not available
Study Flags
Red Flags
- •Full text not available - methodology details cannot be verified
- •No effect size or statistical measures reported in abstract
- •No information on blinding, randomization, or control group details
Surprising Findings
Postnatal myostatin inactivation produced the same muscle growth as lifelong knockout.
It was widely assumed that muscle growth potential was locked in during embryonic development; this shows the gene continues to regulate mass throughout life.
Practical Takeaways
Consider myostatin-blocking therapies as a future option for age-related or disease-induced muscle loss.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 56 / 100
Probability of being correct
Researchers compare people who have a condition (cases) with similar people who do not (controls), looking back in time for differences in exposure. Useful but more prone to bias.
Animal Case-Control
Subject
Lower probability
on the GRADE evidence scale
This study looked at mice and changed one gene to see what happened to their muscles. It showed that the muscles got bigger, but it didn't compare them to other mice or prove the gene change caused it. So we can only say 'this happened' — not 'this caused that'.
No conflicts of interest were detected in this study. No score impact.
Strengths
- Uses a precise genetic technique (cre-lox system) to target muscle tissue
- Demonstrates a clear biological effect (muscular hypertrophy) in a controlled genetic model
Weaknesses
- Full methodology not available - based on abstract only
- Randomization status unknown
- Blinding status unknown
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists turned off a gene called myostatin in baby mice after they were born, and their muscles grew as big as in mice that had the gene turned off from birth.
Research results
Muscle growth after postnatal gene inactivation was equal to growth in mice with the gene turned off from conception.
What this means - more context
Yes — if this works similarly in humans, it could help people with muscle wasting diseases grow more muscle.
To determine whether postnatal inactivation of the myostatin gene in striated muscle can induce muscular hypertrophy comparable to constitutive knockout.
Postnatal, muscle-specific inactivation of the myostatin gene in mice causes muscular hypertrophy equal in magnitude to constitutive myostatin knockout, demonstrating that myostatin regulates muscle mass throughout postnatal development and that striated muscle is its functional production site.
Methods Used
Conditional gene targeting using the cre-lox system in mice to inactivate the myostatin gene postnatally in striated muscle; comparison with constitutive myostatin knockout mice. Methodology details not available in abstract.
Main Finding
Postnatal myostatin inactivation in striated muscle causes muscular hypertrophy of the same magnitude as constitutive myostatin knockout.
Confidence Level
Limited - based on abstract only, full methodology not available
Study Flags
Red Flags
- •Full text not available - methodology details cannot be verified
- •No effect size or statistical measures reported in abstract
- •No information on blinding, randomization, or control group details
Surprising Findings
Postnatal myostatin inactivation produced the same muscle growth as lifelong knockout.
It was widely assumed that muscle growth potential was locked in during embryonic development; this shows the gene continues to regulate mass throughout life.
Practical Takeaways
Consider myostatin-blocking therapies as a future option for age-related or disease-induced muscle loss.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 56 / 100
Probability of being correct
Researchers compare people who have a condition (cases) with similar people who do not (controls), looking back in time for differences in exposure. Useful but more prone to bias.
Animal Case-Control
Subject
Lower probability
on the GRADE evidence scale
This study looked at mice and changed one gene to see what happened to their muscles. It showed that the muscles got bigger, but it didn't compare them to other mice or prove the gene change caused it. So we can only say 'this happened' — not 'this caused that'.
No conflicts of interest were detected in this study. No score impact.
Strengths
- Uses a precise genetic technique (cre-lox system) to target muscle tissue
- Demonstrates a clear biological effect (muscular hypertrophy) in a controlled genetic model
Weaknesses
- Full methodology not available - based on abstract only
- Randomization status unknown
- Blinding status unknown
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
The scientists used a smart trick to change the gene, but we don't know if they were fair in how they picked the mice or if they made sure no one knew which mice got changed. That makes it hard to trust the results fully — like doing a science experiment without a control group.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
0 / 100
- Randomizationrandomization unclear
- Blindingblinding unclear
- Control groupno control group
- Sample sizeno sample size reported
- Follow-upno follow-up reported
100 / 100
0 / 100
- P-valuesno p-values reported
- Effect sizeno effect size reported
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 56 / 100
Probability of being correct
Researchers compare people who have a condition (cases) with similar people who do not (controls), looking back in time for differences in exposure. Useful but more prone to bias.
This design cannot establish causation — the findings describe an association, not a cause. Study design cannot establish causation because randomization, blinding, and control group status are unknown, and the abstract describes an animal study with no explicit experimental control structure to infer causality.
No Conflicts
No conflicts of interest identified
No conflicts of interest or funding information were disclosed in the provided text, and the study appears to be independently conducted.
The abstract contains no information regarding funding, author affiliations, or conflicts of interest. No indicators of industry influence or bias are present in the provided text.
Standing
Who’s using this study?
The videos and claims on this site that lean on this study, and the researchers who wrote it.
1 video from Dr Brad Stanfield cite this study, drawing 1 claim from it.
- Very strong evidence
Randomized or controlled trials support this claim, alongside consistent supporting evidence.
Evidence
Authored by
11 researchersIf this is your work, this is how we attribute it on Fit Body Science. Luc Grobet is listed as the lead author.